SCM
ADCT icon

Sterling Capital Management’s ADC Therapeutics ADCT Stock Holding History

Sterling Capital Management’s Portfolio ADCT Stock Details ADCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.49K Buy
663
+192
+41% +$757 ﹤0.01% 2944
2025
Q4 		$1.66K Buy
471
+295
+168% +$1.2K ﹤0.01% 3088
2025
Q3 		$704 Buy
176
+1
+0.6% +$3 ﹤0.01% 3128
2025
Q2 		$469 Sell
175
-422
-71% -$888 ﹤0.01% 3159
2025
Q1 		$842 Sell
597
-535
-47% -$909 ﹤0.01% 2868
2024
Q4 		$2.25K Buy
1,132
+1,000
+758% +$2.62K ﹤0.01% 2755
2024
Q3 		$416 Buy
+132
New +$416 ﹤0.01% 2943

Other funds holding ADCT

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return